Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device Launches Approvals

New Products In Brief

This article was originally published in The Gray Sheet

  • News

Executive Summary

Merz Aesthetics’ Belotero Balance dermal filler; Gore’s Conformable Gore TAG for thoracic aortic aneurysms; Maquet’s Cardiosave intra-aortic balloon pump. More new products.

You may also be interested in...



New Products In Brief

WL Gore’s endovascular graft for aortic tears and J&J/LifeScan’s OneTouch Verio IQ blood glucose monitor are among new products on the market.

New Products In Brief

Boston Scientific’s next-generation ICDs; Covidien’s SpiderFX embolic protection device; Abbott’s vitamin D assay. More new products.

Merz Pharma Gains Radiesse Dermal Filler Via $253 Mil. BioForm Acquisition

Merz Pharma Group will round out its aesthetic product offerings by adding the Radiesse wrinkle filler device through its $253 million acquisition of BioForm Medical, announced Jan. 4

Table

View full table

Topics

Related Companies

Tags:
Medical Device Launches Approvals
Latest Headlines

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win

See All
UsernamePublicRestriction

Register

MT030749

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By